Novartis Investigative Site

Dk-2730 Herlev 2730

0 studies enrolling now · 1 studies all time

What they study most

Cancer, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed